Frequently Asked Questions
The market is segmented based on , By Type (Branded Peptide, Generic Peptide), Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, Others), Route of Administration (Oral Administration, Parenteral Administration, Pulmonary Administration, Mucosal Administration, Injection Administration) - Industry Trends and Forecast to 2030.
.
The Global Peptide Therapeutics Market size was valued at USD 44699.15 USD Million in 2022.
The Global Peptide Therapeutics Market is projected to grow at a CAGR of 6.3% during the forecast period of 2023 to 2023.
The major players operating in the market include F. Hoffmann La Roche , GlaxoSmithKline plc, Novartis AG, Pfizer , Sanofi, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd, Ipsen Pharma, AstraZeneca, Lonza, Merck Sharp & Dohme Corp., Novo Nordisk A/S, PolyPeptide Group, CordenPharma International.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.
